Evogene Ltd. (EVGN.TA)
ILA 373.5
(0.51%)
ILA 373.5
(0.51%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.64 Million USD | 236.72% |
| 2022 | 1.67 Million USD | 80.11% |
| 2021 | 930 Thousand USD | -10.58% |
| 2020 | 1.04 Million USD | 38.11% |
| 2019 | 753 Thousand USD | -56.9% |
| 2018 | 1.74 Million USD | -48.33% |
| 2017 | 3.38 Million USD | -48.3% |
| 2016 | 6.54 Million USD | -41.23% |
| 2015 | 11.12 Million USD | -23.31% |
| 2014 | 14.51 Million USD | -17.46% |
| 2013 | 17.58 Million USD | 2.98% |
| 2012 | 17.07 Million USD | 14.57% |
| 2011 | 14.9 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.19 Million USD | 624.91% |
| 2024 Q2 | 914 Thousand USD | -78.19% |
| 2023 Q4 | 578 Thousand USD | -84.66% |
| 2023 FY | 5.64 Million USD | 236.72% |
| 2023 Q1 | 641 Thousand USD | -2.88% |
| 2023 Q2 | 654 Thousand USD | 2.03% |
| 2023 Q3 | 3.76 Million USD | 475.99% |
| 2022 FY | 1.67 Million USD | 80.11% |
| 2022 Q4 | 660 Thousand USD | 41.63% |
| 2022 Q3 | 466 Thousand USD | 49.36% |
| 2022 Q2 | 312 Thousand USD | 31.65% |
| 2022 Q1 | 237 Thousand USD | -23.79% |
| 2021 Q3 | 151 Thousand USD | 11.85% |
| 2021 FY | 930 Thousand USD | -10.58% |
| 2021 Q1 | 333 Thousand USD | -5.13% |
| 2021 Q2 | 135 Thousand USD | -59.46% |
| 2021 Q4 | 311 Thousand USD | 105.96% |
| 2020 Q2 | 298 Thousand USD | 297.33% |
| 2020 Q3 | 316 Thousand USD | 6.04% |
| 2020 FY | 1.04 Million USD | 38.11% |
| 2020 Q1 | 75 Thousand USD | -35.34% |
| 2020 Q4 | 351 Thousand USD | 11.08% |
| 2019 Q2 | 192 Thousand USD | -44.83% |
| 2019 Q4 | 116 Thousand USD | 19.59% |
| 2019 Q1 | 348 Thousand USD | -45.2% |
| 2019 FY | 753 Thousand USD | -56.9% |
| 2019 Q3 | 97 Thousand USD | -49.48% |
| 2018 FY | 1.74 Million USD | -48.33% |
| 2018 Q4 | 635 Thousand USD | 73.02% |
| 2018 Q3 | 367 Thousand USD | -3.17% |
| 2018 Q2 | 379 Thousand USD | 3.55% |
| 2018 Q1 | 366 Thousand USD | -50.14% |
| 2017 Q2 | 1.17 Million USD | 63.38% |
| 2017 Q3 | 748 Thousand USD | -36.5% |
| 2017 FY | 3.38 Million USD | -48.3% |
| 2017 Q4 | 734 Thousand USD | -1.87% |
| 2017 Q1 | 721 Thousand USD | -38.9% |
| 2016 Q1 | 2.01 Million USD | -18.15% |
| 2016 Q3 | 1.53 Million USD | -15.04% |
| 2016 FY | 6.54 Million USD | -41.23% |
| 2016 Q4 | 1.18 Million USD | -23.18% |
| 2016 Q2 | 1.8 Million USD | -10.32% |
| 2015 FY | 11.12 Million USD | -23.31% |
| 2015 Q4 | 2.46 Million USD | -25.57% |
| 2015 Q1 | 2.7 Million USD | -25.8% |
| 2015 Q2 | 2.65 Million USD | -1.67% |
| 2015 Q3 | 3.3 Million USD | 24.59% |
| 2014 Q1 | 3.85 Million USD | -12.6% |
| 2014 FY | 14.51 Million USD | -17.46% |
| 2014 Q4 | 3.64 Million USD | 15.04% |
| 2014 Q3 | 3.16 Million USD | -17.82% |
| 2014 Q2 | 3.85 Million USD | -0.18% |
| 2013 Q4 | 4.41 Million USD | 4.23% |
| 2013 Q1 | 4.61 Million USD | -4.19% |
| 2013 FY | 17.58 Million USD | 2.98% |
| 2013 Q2 | 4.31 Million USD | -6.46% |
| 2013 Q3 | 4.23 Million USD | -1.95% |
| 2012 Q2 | 4.08 Million USD | 0.0% |
| 2012 Q3 | 3.96 Million USD | -2.94% |
| 2012 Q4 | 4.81 Million USD | 21.45% |
| 2012 FY | 17.07 Million USD | 14.57% |
| 2011 FY | 14.9 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Matricelf Ltd | - ILA | -Infinity% |